Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Mogamulizumab for Refractory CD3-CD4+ Lymphocytic-Variant Hypereosinophilic Syndrome

Emmanuel Ledoult, Matthieu Groh, Bertrand Meresse, Romain Dubois, Jacques Trauet, Elise Toussaint, Marie Delbeke, Eric Hachulla, Louis Terriou, Adèle De Masson, Michèle Vasseur, Myriam Labalette, David Launay, Jean-Emmanuel Kahn, Guillaume Lefèvre

Blood (2023) 142 (Supplement 1): 4444.

https://doi.org/10.1182/blood-2023-181301

Published: 2023

Journal Articles

Impact of High Donor-Derived CD4 + CCR7 + T Cell Count on Incidence of Grade II-IV Acute Graft-Versus-Host Disease Following Haploidentical Hematopoietic Cell Transplantation

Pauline Varlet, PharmD, Tamim Alsuliman, Jacques Trauet, Julie Demaret, PharmD, PhD, Myriam Labalette, MD PhD, Ibrahim Yakoub-Agha, MD PhD

Blood (2018) 132 (Supplement 1): 5721.

https://doi.org/10.1182/blood-2018-99-116099

Published: 2018

Journal Articles

Low Dose Interleukin-7 Supplementation Increases Intrinsic Cord Blood T Cell Survival without Enhancing Proliferative Alloresponses

Bánádicte Hivert, Jr., Laurent Benjamin Pascal, Jr., Jacques Trauet, Ibrahim Yakoub-Agha, MD, PhD, Myriam Labalette

Blood (2012) 120 (21): 4353.

https://doi.org/10.1182/blood.V120.21.4353.4353

Published: 2012

Journal Articles

Intrinsic Survival Capacity of Cord Blood T cells is heterogeneous and Can Be Promoted by Repeated Low-Doses of Recombinant Interleukin-7,

Eva Deberranger, Laurent B Pascal, Jacques Trauet, Bachra Choufi, MD, Stephanie Thiant, jean-Paul Dessaint, Ibrahim Yakoub-Agha, MD, PhD, Myriam Labalette

Blood (2011) 118 (21): 3227.

https://doi.org/10.1182/blood.V118.21.3227.3227

Published: 2011

Journal Articles

Immune Reactions Following Reduced-Intensity Allogeneic Stem Cell Transplantation (Allo-CST): Role of Plasma IL-7 and IL-15 Levels, and Their Receptors

Thiant Stephanie, Jacques Trauet, Eva De Berranger, Laurent B Pascal, Jean Paul Dessaint, Myriam Labalette, Ibrahim Yakoub-Agha, MD, PhD

Blood (2010) 116 (21): 1251.

https://doi.org/10.1182/blood.V116.21.1251.1251

Published: 2010

NARROW

Mogamulizumab for Refractory CD3-CD4+ Lymphocytic-Variant Hypereosinophilic Syndrome

Impact of High Donor-Derived CD4 + CCR7 + T Cell Count on Incidence of Grade II-IV Acute Graft-Versus-Host Disease Following Haploidentical Hematopoietic Cell Transplantation

Low Dose Interleukin-7 Supplementation Increases Intrinsic Cord Blood T Cell Survival without Enhancing Proliferative Alloresponses

Intrinsic Survival Capacity of Cord Blood T cells is heterogeneous and Can Be Promoted by Repeated Low-Doses of Recombinant Interleukin-7,

Immune Reactions Following Reduced-Intensity Allogeneic Stem Cell Transplantation (Allo-CST): Role of Plasma IL-7 and IL-15 Levels, and Their Receptors

Email alerts

ASH Publications

American Society of Hematology

Mogamulizumab for Refractory CD3-CD4+ Lymphocytic-Variant Hypereosinophilic Syndrome

Impact of High Donor-Derived CD4 + CCR7 + T Cell Count on Incidence of Grade II-IV Acute Graft-Versus-Host Disease Following Haploidentical Hematopoietic Cell Transplantation

Low Dose Interleukin-7 Supplementation Increases Intrinsic Cord Blood T Cell Survival without Enhancing Proliferative Alloresponses

Intrinsic Survival Capacity of Cord Blood T cells is heterogeneous and Can Be Promoted by Repeated Low-Doses of Recombinant Interleukin-7,

Immune Reactions Following Reduced-Intensity Allogeneic Stem Cell Transplantation (Allo-CST): Role of Plasma IL-7 and IL-15 Levels, and Their Receptors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only